afamelanotide (melanotan i) mastery course
Unit 5 of 12
Pivotal Trials in EPP
Endpoint design, efficacy interpretation, and the real clinical meaning of light tolerance.
Reading the Trials
The clinical story is strongest when you read the pivotal EPP trials as disease-function studies, not as vague evidence for generic tanning claims.
Interactive Endpoint Explorer
A quick visual on how baseline, trial exposure, and interpretation fit together.
light-tolerance timeline
Trial Design
Population, design logic, and what the studies were trying to capture.
Endpoints
Why pain-free light exposure and quality of life matter here.
Efficacy Results
What the pivotal program actually showed.
Limitations
What the trials did not prove and where sloppy interpretations begin.